PHAR•benzinga•
Pharming Q4 2024 GAAP EPADS $0.05 Beats $0.01 Estimate, Sales $92.70M Beat $80.74M Estimate
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 13, 2025 by benzinga